What is Eikon Therapeutics (NAS: EIKN) worth?
$971.7Mlast known valuation
Free account
See the evidence behind this price
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Eikon Therapeutics (NAS: EIKN)
- ·The full record, as it builds
Create free account
No card required
Funding history
No rounds on record
No funding rounds for Eikon Therapeutics (NAS: EIKN) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
How Eikon Therapeutics (NAS: EIKN)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Eikon Therapeutics (NAS: EIKN), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Eikon Therapeutics (NAS: EIKN) worth?
- Eikon Therapeutics (NAS: EIKN)'s last known valuation is $971.7M.
- How much has Eikon Therapeutics (NAS: EIKN) raised?
- Eikon Therapeutics (NAS: EIKN) has raised $1.5B in total funding across its recorded rounds.